Modern-day bounty hunters are preparing to fan out across Indiana as the U.S. Department of Health and Human Services expands a program to ferret out fraud and overpayment in the health care system.
Eli Lilly and Co. has launched its new blood thinner prasugrel in its first market, the United Kingdom, Reuters reported today. The drug, sold under the brand name Efient, is priced 31-percent higher than its rival Plavix, the world’s leading blood thinner. Plavix, sold by New York-based Bristol-Myers Squibb Co. and French company Sanofi Aventis […]
Eli Lilly and Co. has launched its new blood thinner prasugrel in its first market, the United Kingdom, Reuters reported today. The drug, sold under the brand name Efient, is priced 31-percent higher than its rival Plavix, the world’s leading blood thinner. Plavix, sold by New York-based Bristol-Myers Squibb Co. and French company Sanofi Aventis […]
Eli Lilly and Co. has sold the rights to sell the diabetes drug Actos in seven countries to Takeda Pharmaceutical Co., Asia’s biggest drugmaker, Bloomberg News reported this morning. Takeda will sell Actos in Canada, Belgium, Denmark, Norway, Sweden and Turkey, a company spokesman told Bloomberg yesterday. Terms of the deal were not disclosed. Takeda […]
Prescribe the wrong dose and some drugs won’t work. Or the patient is as good as dead. Consider the rat-poison-turned-blood-thinner warfarin, also known as Coumadin. Too much and a patient can bleed to death, too little and he can throw a clot and have a stroke. Given the considerable consequences of improper dosing for patients-and […]
Indiana is becoming not only a hotbed of “pharmacogenomics” research, but also a trailblazer in finding practical ways to
use it on the practitioner level.
When it comes to health care reform, Eli Lilly and Co. has its derriere exposed more than its drugmaker peers. That’s according to a recent report by Jason Napodano, a senior pharmaceutical analyst at Zack’s Equity Research. In an April 9 report, he examined potential negatives in President Barack Obama’s health care reform outline. While […]
Indiana exports eked out a gain in 2008 despite the imploding world economy-rising 2 percent to $26.5 billion, according to preliminary data from the U.S. Department of Commerce. All things considered, “exports held up pretty well last year. The last 60 days of the year is really the first time we saw deterioration on the […]
IndyHub, the city’s young professionals network, will launch a new Web site, circlingthecity.com, to pique the interest of out-of-towners who are being recruited by local companies.
Indiana Gov. Mitch Daniels would make a remarkable president. Governor/ presidentâ??it’s the same game, just a different scale.
Indiana’s growing shipments to China averts a reversal in exports for the state, but core transportation equipment takes a
hit.
Familiarity with a foreign culture and its traditions can mean the difference between success and failure, or at least avoiding embarrassment.
When it comes to health care reform, Eli Lilly and Co. has its derriere exposed more than its drugmaker peers.
Eli Lilly and Co.’s profit soared above analysts’ expectations in the three months ended March 31. The Indianapolis-based drugmaker reported earnings per share of $1.20 this morning, well above the 99 cents Wall Street analysts had predicted, according to a survey by Thomson Financial. Lilly said first-quarter profit was $1.3 billion, up 24 percent from […]
Eli Lilly and Co. would buy San Diego-based biotech company Amylin Pharmaceuticals Inc. if corporate raider Carl Icahn gets his way. Icahn, a major investor in Amylin, is pushing for an immediate sale of the company to Indianapolis-based Lilly, according to a letter written by Amylin’s lead independent director, James N. Wilson. Amylin and Lilly […]
Eli Lilly and Co. saw only a slight bump in its share price this morning after reporting first quarter profit that exceeded analysts’ expectations by 21 percent. The Indianapolis-based drugmaker said part of that increase was caused by the rapid rise of the value of the U.S. dollar against foreign currencies. The benefit isn’t likely […]
Indianapolis-based wireless-device distributor Brightpoint Inc. has joined the Fortune 500 for the first time, coming in 496th with $4.6 billion in 2008 revenue, according to the annual list of the nation’s largest companies released yesterday. Other Indiana companies to make the list: WellPoint Inc. (32), Eli Lilly and Co. (122), Cummins Inc. (181), NiSource Inc. […]
Eli Lilly and Co. should win regulatory approval for its blood-thinner prasugrel by the end of the month, according to one Wall Street analyst. Dr. Tim Anderson, an analyst at Sanford C. Bernstein & Co., made the prediction in a note to investors on Tuesday. He added that Wall Street expects prasugrel to receive full approval, despite being dogged […]
A federal judge in Indianapolis blocked today’s planned launch of a generic version of Evista, an osteoporosis and breast cancer drug made by Indianapolis-based Eli Lilly and Co. Sarah Evans Barker granted Lilly a preliminary injunction against Israel-based Teva Pharmaceuticals Industries Ltd. In March, Teva said it would wait until April 23 to launch its […]
While military contractors scramble to protect big projects from Defense Secretary Robert Gates’ budgetary ax, Indianapolis engine-maker Rolls-Royce is sitting pretty. Rolls-Royce, which employs 4,300 in Indianapolis, is developing a key component for the Marine Corps’ version of the F-35 Joint Strike Fighter, potentially a big winner under a sweeping overhaul of priorities Gates unveiled […]
